Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wrinkle Schminkles is an innovative skincare company that specializes in non-invasive anti-aging treatments using medical-grade silicone technology. The company's flagship products are reusable silicone patches designed to treat wrinkles on the chest, forehead, eyes, neck, and mouth by creating a hydrating microclimate that promotes collagen production. These patches are TGA-cleared and FDA-listed as Class 1 Medical Devices, positioning the brand at the intersection of beauty and medical technology. In addition to its signature patches, the company offers a range of complementary topical products, including serums and cleansers infused with active ingredients like hyaluronic acid and peptides. Founded in Australia, Wrinkle Schminkles has established a significant global presence in both the direct-to-consumer market and professional aesthetic channels. The brand is frequently utilized as a needle-free alternative to cosmetic injectables or as a post-operative solution for scar management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wrinkle Schminkles.